Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis

BACKGROUND/AIMS: Fexuprazan is a novel potassium-competitive acid blocker that could be of benefit to patients with gastric mucosal injury. The aim of this study was to assess the 2-week efficacy and safety of fexuprazan in patients with acute or chronic gastritis. METHODS: In this study, 327 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gwang Ha, Choi, Myung-Gyu, Kim, Jin Il, Lee, Soo Teik, Chun, Hoon Jai, Lee, Kook Lae, Choi, Suk Chei, Jang, Jae-Young, Lee, Yong Chan, Kim, Jae Gyu, Kim, Ki Bae, Shim, Ki-Nam, Sohn, Chong Il, Kim, Sung Kook, Kim, Sang Gyun, Jang, Jin Seok, Kim, Nayoung, Jung, Hwoon-Yong, Park, Hyojin, Huh, Kyu Chan, Lee, Kwang Jae, Hong, Su Jin, Baek, Song, Han, Jin Joo, Lee, Oh Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651377/
https://www.ncbi.nlm.nih.gov/pubmed/36789577
http://dx.doi.org/10.5009/gnl220457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651377/
https://www.ncbi.nlm.nih.gov/pubmed/36789577
http://dx.doi.org/10.5009/gnl220457

Ejemplares similares